Delivery Order SPE2DB22D3301-SPE2DB25FY9XT
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,305.14 for IMFINZI 500 mg/10 ml vials on August 25, 2025, with completion anticipated by September 16, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $13,262.85 to AmerisourceBergen Drug Corp for the supply of IMFINZI (500 mg/10 mL vial, 10 mL). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a competitively awarded, non-set-aside procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. IMFINZI is an oncology medication used in cancer...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $23,873.13 for IMFINZI 500 mg/10 mL vials under a firm fixed-price contract with the Defense Department's Medical Supply Chain. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. IMFINZI is a prescription oncology medication, and this order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,830.84 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed-price delivery order, with completion targeted for September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMFINZI 500 MG/10 ML vials valued at $26,525.70 with a firm fixed price structure. This contract is non-set-aside and competitively awarded, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $15,166.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for IMFINZI 500 mg/10 mL vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,305.14 to AmerisourceBergen Drug Corp for Imfinzi 500 mg/10 mL vials on July 31, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025....
- This is a $7,710 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of IMFINZI 500 MG/10 ML vials, a pharmaceutical product. The order has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,952.92 firm fixed-price delivery order contract is for the supply of IMFINZI 500 mg/10 ml vials, a specialty oncology medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...